Answer
Brigatinib targets abnormal ALK signalling, so a validated test is needed to confirm that the cancer is ALK-positive.
Sources for this answer
- Alunbrig 90 mg film-coated tablets — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.